BXRXQ (Baudax Bio) Marketable Securities: $0.00 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BXRXQ Baudax Bio Inc BXRXQ
12 GF Score
Price $0.00
View Full Analysis

What is Baudax Bio Marketable Securities?

Baudax Bio BXRXQ -99.00% 12 Marketable Securities is $0.00 Mil as of Sep. 2023. GuruFocus rates BXRXQ with a GF Score™ of 12/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Baudax Bio's Marketable Securities for the quarter that ended in Sep. 2023 was $0.00 Mil.

Baudax Bio  (OTCPK:BXRXQ) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Baudax Bio Marketable Securities Related Terms

Baudax Bio Marketable Securities Historical Data

* Premium members only.

The historical data trend for Baudax Bio's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baudax Bio Marketable Securities Chart

Baudax Bio Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Baudax Bio Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BXRXQ
12GF Score
Baudax Bio Inc BXRXQ
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baudax Bio Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Baudax Bio (BXRXQ) has a Marketable Securities of $0.00 Mil as of Sep. 2023. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Baudax Bio and its competitors.
Is Baudax Bio's Marketable Securities too high?
Baudax Bio's current Marketable Securities is $0.00 Mil. Overall, Baudax Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Baudax Bio's Marketable Securities compare to INM and NBRVF?
Baudax Bio's Marketable Securities of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Baudax Bio and its competitors. Baudax Bio's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baudax Bio stock overvalued right now?
Baudax Bio (BXRXQ) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Baudax Bio's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Baudax Bio (BXRXQ), the current Marketable Securities is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Baudax Bio Business Description

Address 490 Lapp Road, Malvern, PA, USA, 19355
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs and a dedicated reversal agent.
12GF Score

Get the complete analysis for BXRXQ

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price